Apyx Medical Marks a New Era in Body Contouring with FDA Clearance
The AYON Body Contouring System stands as a pioneering FDA-cleared all-in-one platform tailored for aesthetic surgical suites.
Commercial Launch Plans Ahead
Apyx Medical Corporation (NASDAQ: APYX) is gearing up for an exciting commercial launch of the AYON Body Contouring System. This rollout is slated to engage key opinion leaders in the aesthetic surgery field during the latter part of 2025, allowing for hands-on experience with this innovative technology.
What is the AYON Body Contouring System?
The AYON Body Contouring System is a cutting-edge tool designed by surgeons to provide a comprehensive solution for body contouring treatments. It merges various functionalities, including fat removal, contouring, and tissue tightening, in one platform. The integration of advanced features, such as LIFT Technology and Renuvion, enables surgeons to make real-time adjustments while improving patient outcomes efficiently.
A Broad Range of Applications
This initial FDA clearance for AYON encompasses a variety of aesthetic procedures. These include the use of Renuvion to enhance skin elasticity, ultrasound-assisted liposuction, and electrocoagulation for tissue removal. Apyx Medical is also looking to extend the capabilities of AYON to include power liposuction through an additional regulatory submission.
CEO Insight on AYON's Significance
“This FDA clearance for the AYON Body Contouring System represents a significant advancement in our mission to empower surgeons with transformative technology,” remarked Charlie Goodwin, President and CEO of Apyx Medical Corporation. He highlighted that as more patients turn to GLP-1 medications for rapid weight loss, offering a solution for loose skin and body reshaping has never been more critical. AYON is engineered to meet these evolving demands by providing surgeons with a versatile tool that enhances procedural outcomes.
About Apyx Medical Corporation
Apyx Medical Corporation is an advanced energy technology company committed to enhancing lives through innovative surgical products, including their proprietary Helium Plasma Platform Technology, marketed as Renuvion, and the new AYON Body Contouring System. These products empower surgeons by delivering controlled thermal energy to tissues, yielding precise results aligned with patient needs. Supported by over 90 clinical investigations, Apyx Medical continues to lead in the fields of cosmetic and hospital surgical markets.
Sustaining Innovation in Medical Technology
Incorporating unique waveform technologies through OEM partnerships, Apyx Medical exemplifies its dedication to research and development. This commitment not only fosters innovation but also enhances collaboration with other medical device manufacturers, ensuring that they remain at the forefront of medical advancements.
Contact Information for Investor Relations
If you would like to learn more about Apyx Medical’s initiatives or inquire about their products, please contact Jeremy Feffer, Managing Director of LifeSci Advisors, at 212-915-2568 or via email at jfeffer@lifesciadvisors.com.
Frequently Asked Questions
What does AYON stand for?
AYON refers to Apyx Medical’s Body Contouring System designed for surgical aesthetics.
What technologies are integrated into the AYON System?
The AYON System incorporates precision fat removal, contouring, and electrosurgical capabilities, alongside advanced technologies like LIFT and Renuvion.
What are the anticipated benefits of AYON for surgeons?
AYON aims to enhance procedural efficiency, improve patient outcomes, and streamline the body contouring surgical process.
How does the AYON System cater to the changing needs of patients?
The system provides comprehensive solutions for patients experiencing post-weight loss skin issues, especially those using GLP-1 medications.
How can one learn more about Apyx Medical’s products?
For more information, visit the Apyx Medical Corporation website or reach out to their investor relations contact.
